Law firms Dealwatch: Baker & McKenzie and Ropes & Gray lead on Merck’s $8.4bn superbug takeover Legal Business · 9 December 2014 · 2 min read Corporate and M&A Deal watch US firms Baker McKenzie Ropes & Gray One of the world’s biggest pharma groups, New Jersey-based Merck, instructed an all-female partner team from Baker & McKenzie to help it execute its $8.4bn takeover of Cubist Pharmaceuticals.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this category‘I’m not going to put a cap on growth’ – how Proskauer is capitalising on the real asset boom for its City buildLaw firmsKate Peacock19 Jun 2026‘The velocity of partner movement is pretty incredible’ – New York follows London’s lead on lateralsLaw firmsWill Lewallen19 Jun 2026Bakers’ outgoing London chief on why the firm is doubling down on transactions in the CityLaw firmsTom Cox17 Jun 2026Top US duo tune in as Fox makes $22bn streaming acquisitionLaw firmsKate Peacock15 Jun 2026‘We’re down to earth, we’re fair, we’re ambitious’ – Browne Jacobson hits record £148.8m turnoverLaw firmsTom Cox15 Jun 2026‘There’s a lot of money in Chicago’ – the city’s top lawyers on what’s driving business in the MidwestLaw firmsAlex Ryan13 Jan 2025Legal 500 US: Latham tops the charts in new US rankingsLegal 500 dataBarnaby Merrill28 Jun 2024Dealwatch: Global 100 advisers take centre stage on BlackRock-GIP $12.5bn mega dealLaw firmsAlex Ryan15 Jan 2024Revolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesLaw firmsAnna Huntley9 Jan 2025